W3C home > Mailing lists > Public > public-hcls-dse@w3.org > January to February 2007

RE: Clinical Trial Ontology

From: Dobson, Stephen <Stephen.Dobson@pfizer.com>
Date: Thu, 4 Jan 2007 20:51:24 -0500
Message-ID: <7A20EEC75BBEE542B9E40B92F58E8C5305A3A21A@groamrexm03.amer.pfizer.com>
To: <public-hcls-dse@w3.org>, <public-hcls-dse-request@w3.org>
Hi All, 
I've made a first start at describing some of the context around vital
signs if we can discuss tomorrow I'll add to this and post on the site.
Apologies for not getting out sooner. 

Cheers

Stephen. 



-----Original Message-----
From: public-hcls-dse-request@w3.org
[mailto:public-hcls-dse-request@w3.org] On Behalf Of Forsberg, Kerstin L
Sent: Friday, December 15, 2006 9:44 AM
To: public-hcls-dse@w3.org
Subject: Clinical Trial Ontology 


Hi,
on our wikipage http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy/

in the section Related resources I have added links to

- The Workshop on Clinical Trial Ontology 

- From XML to RDF: how semantic web technologies may change the design 
of clinical standards? A posting on CDISC discussion forum I did last
year with 
a link to the Nature article I briefly mentioned.

Cheers
Kerstin

----------------------------------------------------------------------
LEGAL NOTICE
Unless expressly stated otherwise, this message is confidential and may be privileged.  It is intended for the addressee(s) only.  Access to this E-mail by anyone else is unauthorized.  If you are not an addressee, any disclosure or copying of the contents of this E-mail or any action taken (or not taken) in reliance on it is unauthorized and may be unlawful.  If you are not an addressee, please inform the sender immediately.

Received on Friday, 5 January 2007 01:51:37 GMT

This archive was generated by hypermail 2.2.0+W3C-0.50 : Tuesday, 8 January 2008 14:11:53 GMT